Abstract
Purpose
To evaluate the efficacy of long-tube shunt surgery (LTSS) without valve in uveitic glaucoma (UG) eyes.
Methods
We retrospectively analyzed the data of 45 UG eyes that underwent only LTSS or LTSS combined with trabeculectomy (TLE) (LTSS/TLE). The UG eyes were analyzed by categorizing them into granulomatous/non-granulomatous, steroid responder/non-responder, and primary open-angle glaucoma (POAG) (POAG background)/non-POAG (non-POAG background). All granulomatous UG eyes received a continuous 3-times-daily administration of topical betamethasone post-LTSS.
Results
The eyes consisted of granulomatous (37 eyes, 82%)/non-granulomatous (5 eyes, 11%), steroid responder (19 eyes, 42%)/non-steroid responder (13 eyes, 29%), and 20 eyes with POAG or POAG background (p = 0.0022, 83%) among 24 cases of unilateral UG. The 5-year survival rates of only LTSS and LTSS/TLE were 66% and 100%, respectively. Kaplan–Meier survival-curve estimates in the non-granulomatous group were 100% for 6-year postoperative period, while the granulomatous group showed a gradual decrease along the 6-year (81%) postoperative period. The 5-year survival rates in the steroid responder group and the non-steroid responder group eyes were 74% and 78%, respectively. No intraocular pressure (IOP) elevation was observed in the positive steroid responder eyes post-LTSS.
Conclusions
LTSS and LTSS/TLE were both effective in UG. Positive steroid response may be masked by LTSS in the positive responder eyes. Continuous administration of topical betamethasone post-LTSS may be important for preventing an IOP spike by suppressing inflammation in the anterior chamber. LTSS combined with TLE may be recommended in eyes with granulomatous UG, and the coexistence of a POAG/POAG background.
Similar content being viewed by others
References
Jampel HD, Jabs DA, Quigley HA (1990) Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol 109:168–173
Towler HM, McCluskey P, Shaer B, Lightman S (2000) Long-term follow up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 107:1822–1828
Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 11(3):189–196
Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C (2007) Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol 42:89–94
Kaburaki T, Koshino T, Kawashima H, Numaga J, Tomidokoro A, Shirato S, Araei M (2009) Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye 23:1509–1517
Chawla A, Mercieca K, Fenerty C, Jones NP (2013) Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis. J Glaucoma 22:663–666
Iwao k, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H, (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23:88–94
Iverson SM, Bhardwaj N, Shi W, Sehi M, Greenfield DS, Budenz DL, Kishor K (2015) Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol 59:179–186
Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint JM, Béchetoille A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556–563
Ophir A, Ticho U (1992) Delayed filtering bleb encapsulation. Ophthalmic Surg 23:38–39
Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149–170
Shimizu A, Maruyama K, Yokoyama Y, Tsuda S, Ryu M, Nakazawa T (2014) Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol 26:2383–2389
Ceballos EM, Parrish RK 2nd, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for treatment of uveitic glaucoma. Ophthalmology 109:2256–2260
Tan AN, Cornelissen MF, Webers CAB, Erckens RJ, Berendschot TTJM, Beckers HJM (2018) Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented? Acta Ophthalmol 96:24–30
Da Mata A, Burk SE, Netland PA, Baltatzis CW, Foster CS (1999) Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 106:2168–2172
Ozdal PC, Vianna RN, Deschenes J (2006) Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye 20:178–183
Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, Paczka JA, Gilbert ME, Arellanes-Garcia L (1998) Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm 6:27–37
Molteno AC, Sayawat N, Herbison P (2001) Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 108:605–613
Chhabra R, Tan SZT, Au L, Spencer AF, Fenerty CH, Jones NP (2018) Long-term outcomes and complications of Baerveldt glaucoma drainage implants in adults with glaucoma secondary to uveitis. Ocul Immunol Inflamm 13:1–8
Rachmiel R, Trope GE, Buys YM, Flanagan JG, Chipman ML (2008) Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol 43:462–467
Krishna R, Godfrey DG, Budenz DL, Escalona-Camaano E, Gedde SJ, Greenfield DS, Feuer W, Scott IU (2001) Intermediate-term outcomes of 350-mm(2) Baerveldt glaucoma implants. Ophthalmology 108:621–626
Ritch R (1996) Chapter 55. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas, 2nd edn. Mosby, St Louis, p 1178
Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J; Primary Tube Versus Trabeculectomy Study Group (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663
Bettis DI, Morshedi RG, Chaya C, Goldsmith J, Crandall A, Zabriskie N (2015) Trabeculectomy with mitomycin C or ahmed valve implantation in eyes with uveitic glaucoma. J Glaucoma 24:591–599
Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C, Ruddle J, Crowston JG (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45:472–480
Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10:237–249
Hamanaka T, Takei A, Takemura T, Oritsu M (2002) Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis. Am J Ophthalmol 134:17–26
Hayashi S, Hamanaka T, Takemura T (2012) Pathological study of secondary glaucoma due to congenital syphilis-a new theory of vasculitis in the Schlemm’s canal. J Clin Exp Ophthalmol 3:249
Su CC, Hu FR, Wang TH, Huang JY, Yeh PT, Lin CP, Wang IJ (2014) Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol 158:1024–1031
Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y; Tajimi Study Group, Japan Glaucoma Society (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi study. Ophthalmology 111:1641–1648
Kawamorita S, Hamanaka T, Sakurai T (2014) The early postoperative complications in two different tube ligation methods in Baerveldt implant surgery. J Curr Glaucoma Pract 8:96–100
Hamanaka T, Otora K, Ono K, Ishida N (2014) Long-term results of non-valved Glaucoma drainage implant surgery and glaucoma drainage implant combined with trabeculectomy. Indian J Ophthalmol 62:911–916
Acknowledgements
The authors wish to thank John Bush for editing the manuscript.
Funding
None declared.
Author information
Authors and Affiliations
Contributions
TH was involved in study concept and design, data acquisition, management, and interpretation, drafting of the manuscript, and review of the published literature. SW contributed to data acquisition and interpretation, drafting of the manuscript, and review of the published literature. KK provided data acquisition. NI gave data acquisition and management, and manuscript final version approval. TS analyzed the data. NE was involved in manuscript final version approval.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that there is no conflict of interest.
Ethical approval
This study was approved by the Institutional Review Board (IRB) of the Japanese Red Cross Medical Center, Tokyo, Japan.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Watanabe, S., Hamanaka, T., Sakurai, T. et al. Evaluation of the outcome of long-tube shunt implant surgery in uveitic glaucoma patients by analyzing the background of uveitis. Int Ophthalmol 41, 509–517 (2021). https://doi.org/10.1007/s10792-020-01601-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01601-3